Item 8.01. Other Events.
INmune Bio Inc. (the "Company") is filing as Exhibit 99.1 to this Current Report
on Form 8-K an slide deck that the Company intends to use in a presentation. By
filing this Current Report on Form 8-K and furnishing the information contained
herein, the Company makes no admission as to the materiality of any information
in this report that is required to be disclosed solely by reason of Regulation
FD.
The information contained in the Investor Presentation is summary information
that is intended to be considered in the context of the Company's Securities and
Exchange Commission ("SEC") filings and other public announcements that the
Company may make, by press release or otherwise, from time to time. The Company
undertakes no duty or obligation to publicly update or revise the information
contained in this report, although it may do so from time to time as its
management believes is warranted. Any such updating may be made through the
filing of other reports or documents with the SEC, through press releases or
through other public disclosure.
Item 9.01 Financial statements and Exhibits
(d) Exhibits.
Exhibit Number Description
99.1 Presentation
1
© Edgar Online, source Glimpses